Shivalik Rasayan Limited (BOM:539148)
India · Delayed Price · Currency is INR 254.95
+12.10 (4.98%)
At close: Jul 24, 2026
Shivalik Rasayan Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 3,680 | 3,680 | 3,096 | 2,715 | 2,340 | 2,070 |
Revenue Growth | 18.88% | 18.88% | 14.00% | 16.05% | 13.06% | 5.82% |
Gross Profit Gross Profit Growth | 1,796 | 1,796 | 1,491 | 1,317 | 1,193 | 1,129 |
Operating Income Operating Income Growth | 269.98 | 269.98 | 244.34 | 270.42 | 314.68 | 358.72 |
Net Income Net Income Growth | 121.36 | 121.36 | 166.96 | 127.17 | 207.48 | 256.06 |
Earnings Per Share EPS Growth | 7.71 | 7.71 | 10.60 | 8.35 | 14.32 | 18.12 |
EPS Growth | -27.27% | -27.27% | 26.90% | -41.66% | -20.96% | 41.82% |
| Fiscal Year | TTM | FY 2026 |
|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 |
Agrochemicals (Excl. Pharma Formulation) Agrochemicals (Excl. Pharma Formulation) Growth | 1,513 | 1,513 |
Active Pharma Ingredient (API) Active Pharma Ingredient (API) Growth | 90.48 | 90.48 |
Pharma Formulation Pharma Formulation Growth | 1,978 | 1,978 |
Unallocated Other Operating Unallocated Other Operating Growth | 99.29 | 99.29 |
Total Total Growth | 3,680 | 3,680 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 343.68 | 343.68 | 279.7 | 377.38 | 306.71 | 707.58 |
Total Debt Total Debt Growth | 1,136 | 1,136 | 1,047 | 859.67 | 655.12 | 411.22 |
Net Cash (Debt) Net Cash Growth | -792.75 | -792.75 | -767.57 | -482.29 | -348.41 | 296.36 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -50.36 | -50.36 | -48.73 | -31.68 | -24.05 | 20.97 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -339.59 | -339.59 | -92.03 | -80.75 | -189.49 | 111.34 |
Capital Expenditures CapEx Growth | -166.93 | -166.93 | -226.39 | -676.56 | -632.32 | -249.66 |
Free Cash Flow Free Cash Flow Growth | -506.52 | -506.52 | -318.42 | -757.31 | -821.81 | -138.32 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 48.81% | 48.81% | 48.18% | 48.50% | 50.97% | 54.53% |
Operating Margin | 7.34% | 7.34% | 7.89% | 9.96% | 13.45% | 17.33% |
Pretax Margin | 5.84% | 5.84% | 7.56% | 8.57% | 13.53% | 17.86% |
Profit Margin | 3.30% | 3.30% | 5.39% | 4.68% | 8.87% | 12.37% |
FCF Margin | -13.76% | -13.76% | -10.29% | -27.89% | -35.12% | -6.68% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.500 | 0.500 | 0.500 | 0.500 | 0.500 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 0.20% | 0.22% | 0.08% | 0.09% | 0.07% | 0.05% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 33.07 | 28.78 | 58.37 | 70.67 | 46.96 | 52.79 |
Forward PE | - | 31.43 | 31.43 | 31.43 | 31.43 | 31.43 |
PS Ratio | 1.09 | 0.95 | 3.15 | 3.31 | 4.16 | 6.53 |